Luly Jay R. bought ENTA
November 25, 2025 · Form 4 insider transaction
Luly Jay R. bought 310,000 shares of Enanta Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
310,000
Price
$0.00
Total value
N/A
InsiderLuly Jay R.
Role—
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateNovember 25, 2025
Filing dateNovember 26, 2025
Shares owned after310,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Such option will become exercisable (subject to the optionholder's continued employment) quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over four years from the date of grant (November 25, 2025).